Indivior

Teva holding off launch of opioid addiction drug
Teva holding off launch of opioid addiction drug
Pharmaforum
Teva Pharmaceutical
opioids
opioid addiction
generics
Dr Reddy's
Suboxone
Indivior
Flag link:
As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug
As it fights looming competition on Suboxone, Indivior gets FDA OK on new schizophrenia drug
Endpoints
Indivior
FDA
Perseris
schizophrenia
Suboxone
Flag link:
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Indivior's shares soar 33 percent after U.S. court blocks sale of rival generic
Reuters
Indivior
opioid addiction
generics
Suboxone Film
Dr Reddy's
Flag link:
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Indivior shares dive after Dr Reddy's gets FDA approval for generic
Reuters
Indivior
FDA
generics
Suboxone Film
opioids
opioid addiction
Flag link:
Indivior Files Complaints Asserting New Suboxone Film Patent Against ANDA-Filers
Suboxone Film
opioid addiction
Indivior
Flag link:
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
In a blow to its biggest revenue driver, Indivior loses patent battle with generics maker Alvogen
Endpoints
Indivior
patents
Suboxone
Alvogen
generics
Flag link:
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
12 blockbusters: The surging list of $1B-plus drugs rolling out on the market this year might surprise you
Endpoints
drug launches
Hemlibra
Roche
Biktarvy
Gilead Sciences
Ozempic
Novo Nordisk
Erleada
JNJ
Shingrix
GSK
Patisiran
Alnylam
Sanofi
Epidiolex
GW Pharma
Aimovig
Amgen
Novartis
lanadelumab
Shire
Elagolix
AbbVie
Steglatro
Pfizer
Merck
Sublocade
Indivior
Flag link:
FDA panel votes yes on Indivior’s opioid addiction drug
FDA panel votes yes on Indivior’s opioid addiction drug
Endpoints
FDA
advisory panels
Indivior
opioid addiction
RBP-6000
buprenorphine
Flag link:
Reckitt Benckiser spinout climbs after PhIII schizophrenia trial hits endpoints
Reckitt Benckiser spinout climbs after PhIII schizophrenia trial hits endpoints
Fierce Biotech
Reckitt Benckiser
schizophrenia
RBP-7000
Indivior
Flag link:
Indivior CEO looks beyond 2015 after troubled Reckitt pharma unit's spinoff
Indivior CEO looks beyond 2015 after troubled Reckitt pharma unit's spinoff
Fierce Pharma
Reckitt Benckiser
Indivior
Flag link: